Maxwell D. Leslie

404 total citations
11 papers, 313 citations indexed

About

Maxwell D. Leslie is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Maxwell D. Leslie has authored 11 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in Maxwell D. Leslie's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (2 papers). Maxwell D. Leslie is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (2 papers). Maxwell D. Leslie collaborates with scholars based in United States, Japan and India. Maxwell D. Leslie's co-authors include Eleftherios Michailidis, Stefan G. Sarafianos, Bruno Marchand, Kamalendra Singh, Michael A. Parniak, Karen A. Kirby, Yee Tsuey Ong, Hiroaki Mitsuya, Eiichi Kodama and Emily Ryan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Maxwell D. Leslie

10 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxwell D. Leslie United States 9 250 218 96 75 33 11 313
Florian Leidner United States 11 144 0.6× 96 0.4× 46 0.5× 116 1.5× 45 1.4× 16 260
Murty N. Arimilli United States 8 242 1.0× 152 0.7× 147 1.5× 142 1.9× 48 1.5× 9 410
Margaret Gartland United States 9 201 0.8× 174 0.8× 156 1.6× 82 1.1× 148 4.5× 15 404
Helen Scarnati United States 9 444 1.8× 434 2.0× 56 0.6× 68 0.9× 41 1.2× 12 518
Kristina Prachanronarong United States 9 150 0.6× 71 0.3× 106 1.1× 126 1.7× 89 2.7× 11 329
Derek Hansen United States 4 218 0.9× 194 0.9× 46 0.5× 72 1.0× 17 0.5× 5 282
M. Henes United States 11 138 0.6× 84 0.4× 48 0.5× 102 1.4× 36 1.1× 16 268
Marcia Van Ginderen Belgium 6 336 1.3× 284 1.3× 109 1.1× 135 1.8× 18 0.5× 6 387
Jason Isaacson United States 6 269 1.1× 317 1.5× 58 0.6× 108 1.4× 36 1.1× 6 376
Mary C. Casey United States 13 242 1.0× 204 0.9× 74 0.8× 144 1.9× 29 0.9× 20 337

Countries citing papers authored by Maxwell D. Leslie

Since Specialization
Citations

This map shows the geographic impact of Maxwell D. Leslie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxwell D. Leslie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxwell D. Leslie more than expected).

Fields of papers citing papers by Maxwell D. Leslie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxwell D. Leslie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxwell D. Leslie. The network helps show where Maxwell D. Leslie may publish in the future.

Co-authorship network of co-authors of Maxwell D. Leslie

This figure shows the co-authorship network connecting the top 25 collaborators of Maxwell D. Leslie. A scholar is included among the top collaborators of Maxwell D. Leslie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxwell D. Leslie. Maxwell D. Leslie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Huber, Andrew D., Eleftherios Michailidis, Jing Tang, et al.. (2017). 3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H. Antimicrobial Agents and Chemotherapy. 61(6). 18 indexed citations
2.
Michailidis, Eleftherios, Andrew D. Huber, Emily Ryan, et al.. (2014). 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms. Journal of Biological Chemistry. 289(35). 24533–24548. 79 indexed citations
3.
Huber, Andrew D., Eleftherios Michailidis, Megan L. Schultz, et al.. (2014). SAMHD1 Has Differential Impact on the Efficacies of HIV Nucleoside Reverse Transcriptase Inhibitors. Antimicrobial Agents and Chemotherapy. 58(8). 4915–4919. 23 indexed citations
4.
Michailidis, Eleftherios, Emily Ryan, Atsuko Hachiya, et al.. (2013). Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA. Retrovirology. 10(1). 65–65. 31 indexed citations
5.
Kirby, Karen A., Eleftherios Michailidis, Tracy L. Fetterly, et al.. (2013). Effects of Substitutions at the 4′ and 2 Positions on the Bioactivity of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine. Antimicrobial Agents and Chemotherapy. 57(12). 6254–6264. 36 indexed citations
6.
Hachiya, Atsuko, Bruno Marchand, Eleftherios Michailidis, et al.. (2013). Evaluation of Combinations of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine with Clinically Used Antiretroviral Drugs. Antimicrobial Agents and Chemotherapy. 57(9). 4554–4558. 21 indexed citations
7.
Singh, Kamalendra, Bruno Marchand, K. Devendra, et al.. (2012). Biochemical Mechanism of HIV-1 Resistance to Rilpivirine. Journal of Biological Chemistry. 287(45). 38110–38123. 55 indexed citations
8.
Kirby, Karen A., Bruno Marchand, Yee Tsuey Ong, et al.. (2012). Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 56(4). 2048–2061. 26 indexed citations
9.
Singh, Kamalendra, K. Devendra, Bechan Sharma, et al.. (2012). Biochemical mechanism of clinical resistance to rilpivirine. BMC Infectious Diseases. 12(S1). 1 indexed citations
10.
Singh, Kamalendra, K. Devendra, Maxwell D. Leslie, et al.. (2010). Inhibitors of Foot and Mouth Disease Virus Targeting a Novel Pocket of the RNA-Dependent RNA Polymerase. PLoS ONE. 5(12). e15049–e15049. 21 indexed citations
11.
Vidal, Laura, Maxwell D. Leslie, J Sludden, et al.. (2005). A phase I and pharmacodynamic study of a 7 day infusion schedule of the DNMT1 antisense compound MG98. Journal of Clinical Oncology. 23(16_suppl). 3070–3070. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026